1. Home
  2. LXEO vs RANG Comparison

LXEO vs RANG Comparison

Compare LXEO & RANG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LXEO
  • RANG
  • Stock Information
  • Founded
  • LXEO 2017
  • RANG 2024
  • Country
  • LXEO United States
  • RANG United States
  • Employees
  • LXEO N/A
  • RANG N/A
  • Industry
  • LXEO
  • RANG
  • Sector
  • LXEO
  • RANG
  • Exchange
  • LXEO Nasdaq
  • RANG Nasdaq
  • Market Cap
  • LXEO 140.6M
  • RANG 161.0M
  • IPO Year
  • LXEO 2023
  • RANG 2024
  • Fundamental
  • Price
  • LXEO $2.71
  • RANG N/A
  • Analyst Decision
  • LXEO Strong Buy
  • RANG
  • Analyst Count
  • LXEO 5
  • RANG 0
  • Target Price
  • LXEO $22.20
  • RANG N/A
  • AVG Volume (30 Days)
  • LXEO 1.4M
  • RANG 8.1K
  • Earning Date
  • LXEO 05-08-2025
  • RANG 01-01-0001
  • Dividend Yield
  • LXEO N/A
  • RANG N/A
  • EPS Growth
  • LXEO N/A
  • RANG N/A
  • EPS
  • LXEO N/A
  • RANG N/A
  • Revenue
  • LXEO N/A
  • RANG N/A
  • Revenue This Year
  • LXEO N/A
  • RANG N/A
  • Revenue Next Year
  • LXEO N/A
  • RANG N/A
  • P/E Ratio
  • LXEO N/A
  • RANG N/A
  • Revenue Growth
  • LXEO N/A
  • RANG N/A
  • 52 Week Low
  • LXEO $1.45
  • RANG $9.91
  • 52 Week High
  • LXEO $19.50
  • RANG $10.64
  • Technical
  • Relative Strength Index (RSI)
  • LXEO 48.48
  • RANG N/A
  • Support Level
  • LXEO $1.90
  • RANG N/A
  • Resistance Level
  • LXEO $2.64
  • RANG N/A
  • Average True Range (ATR)
  • LXEO 0.48
  • RANG 0.00
  • MACD
  • LXEO 0.02
  • RANG 0.00
  • Stochastic Oscillator
  • LXEO 51.43
  • RANG 0.00

About LXEO Lexeo Therapeutics Inc.

Lexeo Therapeutics Inc is a a clinical-stage genetic medicines company dedicated to transforming healthcare by applying pioneering science to fundamentally change how disease is treated. Its pipeline consists of candidates targeting patient populations that place significant burden on society and are most amenable to their genetic medicine approach. The Company is focused on preclinical and clinical stage gene therapies, and specifically on hereditary and acquired diseases of high unmet need which is their only business segment.

About RANG Range Capital Acquisition Corp. Ordinary Shares

Range Capital Acquisition Corp is a blank check company.

Share on Social Networks: